Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Gross Profit 2007–2025
Bristol-Myers Squibb Company annual/quarterly gross profit history and growth rate from 2007 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Bristol-Myers Squibb Company gross profit for the quarter ending March 31, 2026 was 8.1 B, a 1.22% decrease year-over-year.
- Bristol-Myers Squibb Company gross profit for the twelve months ending March 31, 2026 was 33.9 B, a 3.81% decrease year-over-year.
- Bristol-Myers Squibb Company annual gross profit for 2025 was 34.3 B, a 0.22% decrease from 2024.
- Bristol-Myers Squibb Company annual gross profit for 2024 was 34.3 B, a 0.06% increase from 2023.
- Bristol-Myers Squibb Company annual gross profit for 2023 was 34.3 B, a 4.74% decrease from 2022.
- Bristol-Myers Squibb Company annual gross profit for 2022 was 36.0 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bristol-Myers Squibb Company Gross Profit — FAQ
Bristol-Myers Squibb Company (BMY) gross profit over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
What is Bristol-Myers Squibb Company's gross profit?
Bristol-Myers Squibb Company (BMY) reported gross profit of $34.26B for fiscal 2025.
Where can I see BMY's gross profit history?
The chart and table above show Bristol-Myers Squibb Company's gross profit by year and by quarter, including the growth rate.